Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Amifostine may be effective in helping blood counts return to normal in treating
patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
advanced myelodysplastic syndrome.